Abstract
The progression of colorectal cancer is commonly characterized by accumulation of genetic or epigenetic abnormalities, altering regulation of gene expression as well as normal protein structures and functions. Nonetheless, there are some questions that remain to be elucidated, such as the origin of cancer cells and populations of cells initiating and propagating tumor development. Currently, there are two rival theories describing the process of carcinogenesis. One is the stochastic model, arguing that any cell is capable of initiating and triggering the development of cancer. Meanwhile, the cancer stem cell model hypothesizes that only a small fraction of stem cells possesses cancer-promoting properties. Typically, colorectal cancer stem cells (CSCs) share the same molecular signaling profiles with normal stem cells or embryonic stem cells, such as Wnt, Notch, TGF-β, and Hedgehog. Nevertheless, CSCs differ from normal stem cells and the bulk of tumor cells in their tumorigenic potential and susceptibility to chemotherapeutic drugs. This may be a possible explanation of the high percentage of cancer recurrence in patients who underwent chemotherapeutic treatment and surgery. This review article focuses on the colorectal cancer stem cell biomarkers and the role of upregulated signaling pathways implicated in the initiation and progression of colorectal cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 1339-1353 |
| Number of pages | 15 |
| Journal | Tumor Biology |
| Volume | 36 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Mar 1 2015 |
Fingerprint
Keywords
- Biomarkers
- Carcinogenesis
- Colorectal cancer
- Signaling pathways
- Stem cells
ASJC Scopus subject areas
- Cancer Research
- Medicine(all)
Cite this
Biomarkers and signaling pathways of colorectal cancer stem cells. / Abetov, Danysh; Mustapova, Zhanar; Saliev, Timur; Bulanin, Denis.
In: Tumor Biology, Vol. 36, No. 3, 01.03.2015, p. 1339-1353.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Biomarkers and signaling pathways of colorectal cancer stem cells
AU - Abetov, Danysh
AU - Mustapova, Zhanar
AU - Saliev, Timur
AU - Bulanin, Denis
PY - 2015/3/1
Y1 - 2015/3/1
N2 - The progression of colorectal cancer is commonly characterized by accumulation of genetic or epigenetic abnormalities, altering regulation of gene expression as well as normal protein structures and functions. Nonetheless, there are some questions that remain to be elucidated, such as the origin of cancer cells and populations of cells initiating and propagating tumor development. Currently, there are two rival theories describing the process of carcinogenesis. One is the stochastic model, arguing that any cell is capable of initiating and triggering the development of cancer. Meanwhile, the cancer stem cell model hypothesizes that only a small fraction of stem cells possesses cancer-promoting properties. Typically, colorectal cancer stem cells (CSCs) share the same molecular signaling profiles with normal stem cells or embryonic stem cells, such as Wnt, Notch, TGF-β, and Hedgehog. Nevertheless, CSCs differ from normal stem cells and the bulk of tumor cells in their tumorigenic potential and susceptibility to chemotherapeutic drugs. This may be a possible explanation of the high percentage of cancer recurrence in patients who underwent chemotherapeutic treatment and surgery. This review article focuses on the colorectal cancer stem cell biomarkers and the role of upregulated signaling pathways implicated in the initiation and progression of colorectal cancer.
AB - The progression of colorectal cancer is commonly characterized by accumulation of genetic or epigenetic abnormalities, altering regulation of gene expression as well as normal protein structures and functions. Nonetheless, there are some questions that remain to be elucidated, such as the origin of cancer cells and populations of cells initiating and propagating tumor development. Currently, there are two rival theories describing the process of carcinogenesis. One is the stochastic model, arguing that any cell is capable of initiating and triggering the development of cancer. Meanwhile, the cancer stem cell model hypothesizes that only a small fraction of stem cells possesses cancer-promoting properties. Typically, colorectal cancer stem cells (CSCs) share the same molecular signaling profiles with normal stem cells or embryonic stem cells, such as Wnt, Notch, TGF-β, and Hedgehog. Nevertheless, CSCs differ from normal stem cells and the bulk of tumor cells in their tumorigenic potential and susceptibility to chemotherapeutic drugs. This may be a possible explanation of the high percentage of cancer recurrence in patients who underwent chemotherapeutic treatment and surgery. This review article focuses on the colorectal cancer stem cell biomarkers and the role of upregulated signaling pathways implicated in the initiation and progression of colorectal cancer.
KW - Biomarkers
KW - Carcinogenesis
KW - Colorectal cancer
KW - Signaling pathways
KW - Stem cells
UR - http://www.scopus.com/inward/record.url?scp=84930899800&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930899800&partnerID=8YFLogxK
U2 - 10.1007/s13277-015-3198-4
DO - 10.1007/s13277-015-3198-4
M3 - Article
C2 - 25680406
AN - SCOPUS:84930899800
VL - 36
SP - 1339
EP - 1353
JO - Tumor Biology
JF - Tumor Biology
SN - 1010-4283
IS - 3
ER -